AdvisorShares Psychedelics ETF Rating $16.63 +0.12 (+0.73%) As of 02:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingModerate Buy 2.91Holdings in PSIL have an aggregate rating of Moderate Buy based on 91 analyst ratings issued in the past year covering 13 companies (74.2% of the portfolio).PSIL Aggregate Price Target$16.59-0.24% DownsideHigh Prediction$16.59Average Prediction$16.59Low Prediction$16.59Holdings in PSIL have an aggregate price target of $16.59 and a range of $16.59 to $16.59 covering 13 companies (74.2% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy4 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 13 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.43%ATAIatai Life Sciences$4.11-1.1%3.026 of 5 stars3.40$11.25 174.1%5Upcoming EarningsShort Interest ↑Gap Up8.06%NRXPNRx Pharmaceuticals$2.50+1.4%2.8966 of 5 stars3.20$28.50 1,042.3%5News CoverageUpcoming Earnings7.69%MNMDMind Medicine (MindMed)$9.76-2.3%2.0649 of 5 stars3.22$24.71 153.3%9Trending NewsAnalyst RevisionGap Up7.11%ALKSAlkermes$26.76+0.6%4.7828 of 5 stars2.83$41.08 53.5%12Positive News7.00%SAGESage Therapeutics$8.683.7021 of 5 stars1.93$7.85 -9.6%145.86%CMPSCOMPASS Pathways$4.36+1.0%2.8027 of 5 stars2.86$16.29 274.0%7News CoverageAnalyst Revision5.67%GHRSGH Research$12.40+2.5%2.7592 of 5 stars3.00$32.00 158.0%7Positive NewsEarnings Report5.67%NBIXNeurocrine Biosciences$124.41-0.9%4.9667 of 5 stars2.86$160.90 29.3%225.01%STIMNeuronetics$4.18+4.2%1.163 of 5 stars2.67$5.00 19.6%3Earnings ReportAnalyst Forecast4.60%VTGNVistaGen Therapeutics$2.93+7.3%0.868 of 5 stars3.001News CoverageEarnings Report4.60%NEUPNeuphoria Therapeutics$7.59-2.1%1.1784 of 5 stars3.00$21.00 176.7%12.21%RLMDRelmada Therapeutics$0.59-2.1%4.5355 of 5 stars2.25$5.00 748.9%4News CoverageNegative NewsEarnings Report1.27%ENVBEnveric Biosciences$1.12+0.5%2.3175 of 5 stars3.00$10.00 796.9%1Upcoming EarningsGap Up This page (NYSEARCA:PSIL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
